Rossi, Elena
 Distribuzione geografica
Continente #
NA - Nord America 2.179
EU - Europa 1.846
AS - Asia 362
AF - Africa 22
SA - Sud America 15
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.437
Nazione #
US - Stati Uniti d'America 2.167
DE - Germania 558
SE - Svezia 407
IT - Italia 289
CN - Cina 240
UA - Ucraina 133
IE - Irlanda 117
FR - Francia 98
PL - Polonia 89
GB - Regno Unito 57
SG - Singapore 46
FI - Finlandia 34
IN - India 29
CI - Costa d'Avorio 15
AT - Austria 12
RU - Federazione Russa 12
BE - Belgio 11
AU - Australia 9
CA - Canada 9
IR - Iran 8
TR - Turchia 8
BR - Brasile 6
CH - Svizzera 5
ES - Italia 5
JP - Giappone 5
KR - Corea 5
RO - Romania 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
DZ - Algeria 3
HK - Hong Kong 3
IQ - Iraq 3
MY - Malesia 3
VN - Vietnam 3
CL - Cile 2
HU - Ungheria 2
MX - Messico 2
NL - Olanda 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
KH - Cambogia 1
LI - Liechtenstein 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 4.437
Città #
Chandler 474
Ashburn 209
Dublin 114
Wilmington 91
San Mateo 85
Jacksonville 81
Fairfield 79
Warsaw 74
Ann Arbor 65
Nanjing 60
Dearborn 59
Cattolica 58
Milan 57
Woodbridge 56
Houston 53
New York 53
Rome 51
Boston 49
Seattle 39
Princeton 38
Marseille 37
Redwood City 32
Lawrence 25
Nürnberg 25
Beijing 24
Singapore 24
Detroit 23
Redmond 23
Nanchang 22
Chicago 21
Cambridge 19
Hangzhou 18
Los Angeles 18
Hebei 17
Abidjan 15
Kraków 15
Boardman 14
Norwalk 14
Leawood 13
Washington 13
Brussels 11
Munich 10
Bremen 9
Changsha 9
Florence 9
Mountain View 9
San Diego 9
Tianjin 9
Toronto 8
Kunming 7
Pune 7
Busto Arsizio 6
London 6
University Park 6
Vienna 6
Helsinki 5
Izmir 5
Jiaxing 5
Lancaster 5
Perugia 5
Shenyang 5
Simi Valley 5
Andover 4
Clearwater 4
Fremont 4
Glendale 4
Guangzhou 4
Hefei 4
Hounslow 4
Peterborough 4
São Paulo 4
Vladivostok 4
Zhengzhou 4
Baotou 3
Bolzano 3
Busan 3
Cape Town 3
Changchun 3
Dong Ket 3
Hong Kong 3
Jinan 3
Paris 3
Sacramento 3
San Francisco 3
Southend 3
Algiers 2
Amsterdam 2
Bagnacavallo 2
Bagnoli Irpino 2
Bern 2
Bologna 2
Budapest 2
Buenos Aires 2
Canberra 2
Chester Springs 2
Essen 2
Falkenstein 2
Ferrara 2
Fuzhou 2
Genzano di Roma 2
Totale 2.523
Nome #
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 258
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 254
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 184
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 159
Risk factor and etiology analysis of ischemic stroke in young adult patients 138
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 108
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 106
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 104
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 101
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 100
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 99
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 98
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 97
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 92
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 90
Venous thromboembolism in multiple myeloma 88
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 87
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 86
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 85
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 78
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 74
Inherited thrombophilia: treatment during pregnancy. 73
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 70
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 69
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 66
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 64
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 64
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 64
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 62
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 60
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 60
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 60
Isolated light chain deposition disease neuropathy in a patient with multiple myeloma 60
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 60
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 59
Assessment of congenital neutropenia in children: common clinical sceneries and clues for management 58
Structural analysis of protein Z gene variants in patients with foetal losses 52
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years 52
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 52
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 51
Venous thromboembolism in patients with liver diseases 46
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study 46
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 44
Cerebral sinus-venous thrombosis 43
Real-world use of thrombopoietin receptor agonists in elderly patients with primary immune thrombocytopenia 42
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 41
G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 39
Venous thromboembolism in patients with liver diseases 38
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 38
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases 38
Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis? 37
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 36
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 36
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 35
Second cancers in MPN: Survival analysis from an international study 35
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: An expert consensus 34
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms 31
Reassessment of contractile reserve after revascularization of akinetic myocardium 31
Contractile reserve of dysfunctional myocardium after revascularization: A dobutamine stress echocardiography study 30
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 30
Glycoprotein la C807T qene polymorphism and increased risk of recurrent acute coronary syndromes: A five year follow up 26
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 25
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases 25
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 22
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 20
Left atrial myxoma supplied from the right coronary artery 14
Risk factor and etiology analysis of ischemic stroke in young adult patients 7
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis 7
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 7
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 3
Glycoprotein IA C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. 3
G20210A protrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 2
Totale 4.553
Categoria #
all - tutte 18.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 0 0 11
2019/2020561 102 28 32 48 44 74 41 15 39 32 63 43
2020/2021467 26 42 20 55 48 37 50 22 54 25 75 13
2021/2022659 46 34 16 39 31 12 20 80 45 45 118 173
2022/20231.331 198 194 114 197 74 155 79 82 151 25 33 29
2023/2024650 28 170 30 51 33 120 36 39 14 31 77 21
Totale 4.553